Communications
815 – 819; for borrelidin, see: J.Berger, L.M.Jampolsky, M.W.
Goldberg, Arch. Biochem. 1949, 22, 476 – 478; for pectinatone,
see: J.E.Biskupiak, C.M.Ireland, Tetrahedron Lett. 1983, 24,
3055 – 3058.
ally more convenient for small-scale reactions.The primary
alcohols formed in the first step were therefore converted into
the corresponding iodides (Scheme 3, step 2).The halogen–
metal exchange proceeded cleanly upon treatment with tert-
butyllithium and was followed by transmetalation with
MgBr2·OEt2.The directed allylic substitution of the resulting
Grignard reagents with (S)-(À)-8 and (R)-(+)-8 in the
presence of CuBr·SMe2 (0.5 equiv) proceeded cleanly to
give all four possible diastereomeric tris(deoxypropionate)
building blocks 15–18 in good yield, with perfect regioselec-
tivity and excellent stereoselectivity.
[2] D.A.Evans, R.L.Dow, T.L.Shih, J.M.Takacs, R.Zahler,
J.
Am. Chem. Soc. 1990, 112, 5290 – 5313.
[3] A.G.Myers, B.H.Yang, H.Chen, D.J.Kopecky,
457 – 459.
Synlett 1997,
[4] A.A. Birkbeck, D. Enders, Tetrahedron Lett. 1998, 39, 7823 –
7826.
[5] B.Breit, P.Demel, C.Studte,
Angew. Chem. 2004, 116, 3874–
3877; Angew. Chem. Int. Ed. 2004, 43, 3786–3789; B.Breit, P.
Demel, Adv. Synth. Catal. 2001, 343, 429 – 432.
In conclusion, a new flexible iterative strategy has been
developed for the preparation of any desired oligo(deoxy-
propionate) stereoisomer.The key step, which allows perfect
control of all aspects of selectivity, is an o-DPPB-directed
copper-mediated allylic substitution with an enantiomerically
pure Grignard reagent.This fragment-coupling step features
reversed polarity relative to established methodology involv-
ing enolate alkylation.Problems associated with strategies
based on enolate alkylation, such as low enolate reactivity and
the cost of the chiral auxiliary, which is also often difficult to
remove, can thus be avoided.
[6] a) Novozym 435 is a lipase from Candida antarctica (Candida
zymes.com; b) for selected examples of 2-alkanols that have
been resolved with CAL-B, see: U.T. Bornscheuer, R.J.
Kazlauskas in Hydrolases in Organic Synthesis, Wiley-VCH,
Weinheim, 1999, pp.70 – 72.
[7] D.Sawada, M.Kanai, M.Shibasaki, J. Am. Chem. Soc. 2000, 122,
10521 – 10532.
[8] For the synthesis of (S)-10, see: SD. .Meyer, T.Miwa, M.
Nakatsuka, S.L.Schreiber, J. Org. Chem. 1992, 57, 5058 – 5060.
[9] a) E.Santaniello, P.Ferraboschi, P.Grisenti, Tetrahedron Lett.
1990, 31, 5657 – 5660; b) C.Bertucci, A.Petri, G.Felix, B.Perini,
P.Salvadori, Tetrahedron: Asymmetry 1999, 10, 4455 – 4462; c) P.
Grisenti, P.Ferraboschi, A.Manzocchi, E.Santaniello, Tetrahe-
dron 1992, 48, 3827 – 3834; d) Z.-F. Xie, H. Suemune, K. Sakai,
Tetrahedron: Asymmetry 1993, 4, 973 – 980.
Experimental Section
Synthesis of (+)-13: CuBr·SMe2 (20.6 mg, 0.10 mmol) was added to a
solution of (À)-8 (77.7 mg, 0.20 mmol) in diethyl ether (4 mL) at
room temperature, and the reaction mixture was stirred for a further
5 min.The Grignard reagent 12 (2.4 mL, 0.24 mmol, 0.1m solution in
diethyl ether) was added dropwise at room temperature to the
resulting yellow solution, and the mixture was stirred for a further 2 h.
A saturated aqueous solution of NH4Cl (2 mL) was then added to the
reaction mixture, the phases were separated, and the aqueous phase
was extracted with dichloromethane (3 5 mL).The combined
organic phases were dried (Na2SO4) and the solvents were removed
in vacuo.Flash chromatography of the residue (petroleum ether/ tert-
butyl methyl ether 50:1) yielded (+)-13 as a colorless oil (45.9 mg,
83%, d.r. 97:3). HPLC (Macherey-Nagel EC 250/4 Nucleosil 100-5,
[10] T.Akeboshi, Y.Ohtsuka, T.Ishihara, T.Sugai, Adv. Synth. Catal.
2001, 343, 624 – 637.
[11] P.M.Smith, E.J.Thomas, J. Chem. Soc. Perkin Trans. 1 1998,
3541 – 3556.
[12] K.V.Baker, J.M.Brown, N.Hughes, A.J.Skarnulis, A.Sexton,
J. Org. Chem. 1991, 56, 698 – 703.
[13] S.Karlsson, E.Hedenstrꢀm, Acta Chem. Scand. 1999, 53, 620 –
630.
[14] For (À)-20, see: P.J.Kocienski, R.C.D.Brown, A.Pommier, M.
Procter, B.Schmidt, J. Chem. Soc. Perkin Trans. 1 1998, 9 – 40.
0.4 25 cm, 258C, n-heptane/ethyl acetate (200:0.3), 0.8 mLminÀ1
,
275 nm): tR ((À)-13): 52.4 min (2.8%), tR ((+)-13): 55.0 min (97.2%);
[a]2D0 = +18.2 (c = 0.68, CHCl3); 1H NMR (499.873 MHz, CDCl3,
3
3
278C, TMS): d = 0.91 (d, J = 6.8 Hz, 3H, CH3), 0.92 (d, J = 6.8 Hz,
3
2
3
3H, CH3), 0.95 (t, J = 7.5 Hz, 3H, CH3), 1.08 (dt, J = 13.5 Hz, J =
7.5 Hz, 1H, CH2), 1.29 (mc, 1H, CH2), 1.81 (mc, 1H, CH), 1.98 (mc,
2
3
2H, CH2), 2.14 (mc, 1H, CH), 3.18 (dd, J = 9.1 Hz, J = 7.1 Hz, 1H,
CH2), 3.32 (dd, 2J = 9.1 Hz, 3J = 5.4 Hz, 1H, CH2), 3.80 (s, 3H, O-
2
CH3), 4.41 (d, J = 11.7 Hz, 1H, CH2Ar), 4.44 (d, 2J = 11.7 Hz, 1H,
3
4
CH2Ar), 5.25 (ddt, J = 15.3, 7.6 Hz, J = 1.4 Hz, 1H, CH), 5.38 (dtd,
3J = 15.3, 6.2 Hz, 4J = 0.9 Hz, 1H, CH), 6.87 (m, 2H, ArH), 7.26 ppm
(m, 2H, ArH); 13C NMR (125.709 MHz, CDCl3, 278C, TMS): d =
14.0, 17.7, 20.7, 25.5, 31.0, 34.0, 41.2, 55.3, 72.6, 75.6, 113.7 (2 C),
129.1 (2 C), 129.9, 131.0, 135.6, 159.0 ppm; elemental analysis (%)
calcd for C18H28O2 (276.41): C 78.21, H 10.21; found: C 77.90, H 10.32.
Received: February 11, 2004 [Z53990]
Published Online: May 26, 2004
Keywords: allylation · asymmetric synthesis ·
.
diastereoselectivity · organocopper reagents · polyketides
[1] For ionomycin, see: W-.C.Liu, D.Smith-Slusarchyk, G.Astle,
W.H. Trejo, W.E. Brown, E.J. Meyers,
J. Antibiot. 1978, 31,
3792
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2004, 43, 3790 –3792